GWP GW Pharm.

RNS Number:5245Q
GW Pharmaceuticals PLC
25 January 2002


                                  SCHEDULE 11

          NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
AVS NO


        All relevant boxes should be completed in block capital letters.

1.   Name of company                                     2.   Name of director

     GW Pharmaceuticals PLC                                   Justin Gover

3.   Please state whether notification indicates that it 4.   Name of the registered holder(s) and, if more than one
     is in respect of holding of the shareholder named        holder, the number of shares held by each of them (if
     in 2 above or in respect of a non-beneficial             notified)
     interest or in the case of an individual holder if
     it is a holding of that person's spouse or children
     under the age of 18 or in respect of an
     non-beneficial interest see 23 below




5.   Please state whether notification relates to a      6.   Please state the nature of the transaction. For PEP
     person(s) connected with the director named in 2         transactions please indicate whether general/single
     above and identify the connected person(s)               co PEP and if discretionary/non discretionary/non
                                                              discretionary

7.   Number of shares/      8.    Percentage of issued   9.   Number of shares/amount of 10.  Percentage of issued class
     amount of stock              class                       stock disposed
     acquired





11. Class of security      12.   Price per share        13.    Date of transaction      14.   Date company informed

15.  Total holding following this notification           16.    Total percentage holding of issued class following this
                                                                notification


If a director has been granted options by the company please complete the following boxes.


17.  Date of grant                                       18.  Period during which or date on which exercisable

          23 January 2002                                          23 January 2005

19.  Total amount paid (if any) for grant of the option  20.  Description of shares or debentures involved: class,
                                                              number
          n/a
                                                                   2,450 Ordinary shares of 0.1p each

21.  Exercise price (if fixed at time of grant) or       22.  Total number od shares or debentures over which options
     indication that price is to be fixed at time of          held following this notification
     exercise
                                                                   N/A
          Nil, See 23 below

23.  Any additional information                          24.  Name of contact and telephone number for queries

     Free shares conditionally gifted under the rules of           Jonathan Laughton
     the GW Pharmaceuticals All Employee Share Scheme,
     and held in trust by the GWP Trustee Company                  + 44 (0) 1980 557 000
     Limited.

     The main condition is that the director must remain
     an employee of the Company for three years from the
     date of issue and the shares will be held by the
     trust until that time"

25.  Name and signature of authorised company official responsible for making this notification

          Jonathan Laughton, Company Secretary


Date of notification 25 January 2002


        Company Announcements Office, Old Broad Street, London EC2N 1HP

        Facsimile: 020 7588 6057, 020 7334 8964/8965/8966 (PLEASE DO NOT POST)

        Enquiries: Company Monitoring; UK Listing Authority



                      This information is provided by RNS
            The company news service from the London Stock Exchange

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024